The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

Metan G., Agkus C., Buldu H., KOÇ A. N.

INFECTION, cilt.38, sa.3, ss.217-221, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 3
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1007/s15010-010-0003-6
  • Dergi Adı: INFECTION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.217-221
  • Anahtar Kelimeler: Aspergillus galactomannan antigen, 1,3-Beta-D-glucan, False positivity, Piperacillin/tazobactam, HEMATOLOGICAL MALIGNANCIES, ENZYME-IMMUNOASSAY, TAZOBACTAM, DIAGNOSIS, PROPHYLAXIS, ANTIGENEMIA, KINETICS
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

The aim of this study was to investigate the interaction between intravenous piperacillin/tazobactam treatment and Aspergillus galactomannan antigen (GM) and 1,3-beta-d-glucan (BDG) test results in patients without known risk factors for invasive fungal infections (IFI).